医思健康是一家主要从事提供医疗及保健服务的投资控股公司。该公司主要通过三个业务分部进行运 营。医疗服务分部提供医疗服务及牙科服务等。美学医疗、美容及养生服务分部提供美学医疗、传统美 容、护发及辅助养生服务以及销售护肤、保健及美容产品。其他分部提供营销及相关服务以及兽医服 务。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 证券之星消息，1月8日南向资金减持3.9万股医思健康（02138.HK）。近5个交易日中，获南向资金减持 的有5天，累计净减持48.3万股。近20个交易日中，获南向资金减持的有20天，累计净减持118.5万股。 截至目前，南向资金持有医思健康（02138.HK）2019.4万股，占公司已发行普通股的1.7%。 ...

Core Viewpoint - The article highlights the importance of accurate and responsible information disclosure by listed companies, using the case of Meili Tianyuan Medical Health Industry Co., Ltd. as an example of a company that made significant errors in its financial announcements, reflecting a lack of rigor in its reporting practices [1][2]. Financial Performance - Meili Tianyuan's preliminary performance forecast indicated expected revenue of at least RMB 14.5 billion for the six months ending June 30, 2025, representing a growth of at least 27% compared to the same period in 2024 [2]. - The adjusted net profit was initially reported as at least RMB 17.5 million, later corrected to RMB 175 million, showing a growth of at least 33% year-on-year [2][3]. - The company reported a net profit of at least RMB 17 million, later corrected to RMB 170 million, reflecting a growth of at least 35% compared to 2024 [2][3]. Business Strategy - Meili Tianyuan employs a "dual growth" strategy of "internal growth + external mergers," which has led to significant business expansion and market share increase [2][4]. - The company has seen steady growth in revenue and net profit since its listing, with revenues of RMB 21.45 billion and net profits of RMB 2.3 billion in 2023, and projected revenues of RMB 25.72 billion and net profits of RMB 2.52 billion in 2024 [4]. Market Position - The acquisition of a 70% stake in the second-largest beauty brand, Nairui Health Technology Co., Ltd., for RMB 350 million has enhanced Meili Tianyuan's market position and contributed to its revenue growth [4][5]. - As of December 31, 2024, the company had over 554 stores across more than 100 cities, indicating a robust expansion of its operational footprint [4]. Stock Market Performance - As of August 8, the stock price of Meili Tianyuan was HKD 27.2 per share, with a total market capitalization of HKD 64.14 billion [6].